Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Diabetic Ketoacidosis Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.

Literature DB >> 27311492

Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Diabetic Ketoacidosis Among Patients With Type 2 Diabetes: A Meta-analysis of Randomized Controlled Trials.

Huilin Tang¹, Dandan Li², Tiansheng Wang³, Suodi Zhai⁴, Yiqing Song⁵.

Abstract

Entities: Disease Species

Year: 2016 PMID： 27311492 DOI： 10.2337/dc16-0885

Source DB: PubMed Journal: Diabetes Care ISSN： 0149-5992 Impact factor: 19.112

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes.

Authors: Taichi Nagahisa; Yoshifumi Saisho
Journal: Diabetes Ther Date: 2019-08-22 Impact factor: 2.945

Review 2. Empagliflozin: A Review in Type 2 Diabetes.

Authors: James E Frampton
Journal: Drugs Date: 2018-07 Impact factor: 9.546

Review 3. SGLT2-I in the Hospital Setting: Diabetic Ketoacidosis and Other Benefits and Concerns.

Authors: Joshua A Levine; Susan L Karam; Grazia Aleppo
Journal: Curr Diab Rep Date: 2017-07 Impact factor: 4.810

Review 4. Management of Hyperglycemic Crises: Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State.

Authors: Maya Fayfman; Francisco J Pasquel; Guillermo E Umpierrez
Journal: Med Clin North Am Date: 2017-05 Impact factor: 5.456

Review 5. Glycemic Control in Hospitalized Stroke Patients: A Review.

Authors: Vishal N Patel; Emory Kuo
Journal: Curr Diab Rep Date: 2021-12-01 Impact factor: 4.810

6. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors: Melanie J Davies; David A D'Alessio; Judith Fradkin; Walter N Kernan; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Apostolos Tsapas; Deborah J Wexler; John B Buse
Journal: Diabetologia Date: 2018-12 Impact factor: 10.122

Review 7. The efficacy and safety of SGLT2 inhibitors for adjunctive treatment of type 1 diabetes: a systematic review and meta-analysis.

Authors: Jiao Chen; Fang Fan; J Y Wang; Yang Long; C L Gao; R C Stanton; Yong Xu
Journal: Sci Rep Date: 2017-03-09 Impact factor: 4.379

Review 8. What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?

Authors: Marc Evans; Angharad R Morgan; Zaheer Yousef
Journal: Diabetes Ther Date: 2019-08-13 Impact factor: 2.945

9. Prolonged glucosuria and relapse of diabetic ketoacidosis related to SGLT2-inhibitor therapy.

Authors: Gregory P Westcott; Alissa R Segal; Joanna Mitri; Florence M Brown
Journal: Endocrinol Diabetes Metab Date: 2020-02-29

10. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).